CTRI/2026/07/114091进行中（未招募）不适用
A true experimental study to assess the effectiveness of video based intervention on medication adherence among hypertensive patients attending selected OPDs at AIIMS Bhopal. - nil
Monika0 个研究点目标入组 82 人开始时间: 2026年8月3日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 18 years and above.
- •Present at the data collection time.
- •Willing to participate in the study.
- •Diagnosed hypertension on antihypertensive medication for more then one month.
- •Able to understand English and Hindi language, the local language used in the video
- •Willing to provide written informed consent.
排除标准
- •known case of severe cognitive impairment and psychiatric illness.
- •not willing to participate.
- •An individual diagnosed with hearing and visual impairment.
- •hospitalised and critically ill patients.
- •Participate in another adherence intervention.
研究者
相似试验
尚未招募
不适用
Use Of Cucumber Peppermint Oil Ice Cube For Oral MucositisCTRI/2025/07/09210980
招募中
1 期
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid TumorsAdvanced Malignant Solid Tumors2025-523931-21-00Genmab A/S77
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal FunctionjRCT2031260268118